© 1998 by European Society of Cardiology
Copyright © 1998, European Society of Cardiology
The endothelin A receptor antagonist LU 135252 protects the myocardium from neutrophil injury during ischaemia/reperfusion
Department of Cardiology, Karolinska Hospital, 171 76 Stockholm, Sweden
* Corresponding author. Tel.: +46-8-517-73560; Fax: +46-8-311-044.
Objective: Endothelin-1 (ET-1) is not only a potent vasoconstrictor but also a stimulator of polymorphonuclear leukocyte (PMN) aggregation and adhesion. The aim of this study was to investigate whether an ETA receptor antagonist attenuates the PMN-mediated contractile dysfunction following myocardial ischaemia. Methods: Isolated rat hearts were perfused according to the Langendorff method. The hearts were subjected to global ischaemia and reperfused with buffer solution only, or human PMNs dissolved in rat plasma (HNRP). Results: In an initial study, the ETA receptor antagonist LU 135252 (1 and 10 µmol/l) or ET-1 (1 and 10 nmol/l) did not significantly affect the recovery of left ventricular developed pressure (LVDP), end-diastolic pressure (LVEDP), the first derivative of left ventricular pressure (dP/dt) or the rate pressure product (RPP) during reperfusion with buffer solution only compared to a vehicle group. In a second study on hearts reperfused with HNRP, administration of LU 135252 (10 µmol/l) significantly enhanced the recovery of LVDP, dP/dt and RPP in hearts reperfused with HNRP. LVEDP was 20 mmHg lower in hearts given LU 135252 than vehicle in combination with HNRP (P<0.05). The outflow of PMNs in the coronary effluent during reperfusion was 41±8% in hearts given LU 135252 compared to 9±5% in vehicle-treated hearts (P<0.01). There was a significant correlation between the myocardial functional recovery and the outflow of PMNs. Administration of ET-1 (0.1 and 1 nmol/l) in combination with HNRP resulted in complete loss of contractile function and no outflow of PMNs during reperfusion. Conclusion: The ETA receptor antagonist LU 135252 protects from ischaemia/reperfusion injury in the isolated rat heart in the presence of PMNs. It is suggested that inhibition of PMN-induced injury during reperfusion is an important cardioprotective action of LU 135252.
KEYWORDS Endothelin-1; ETA receptor; LU 135252; Neutrophils; Ischaemia; Reperfusion; Rat
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A. T. Gonon, D. Erbas, A. Broijersen, G. Valen, and J. Pernow Nitric oxide mediates protective effect of endothelin receptor antagonism during myocardial ischemia and reperfusion Am J Physiol Heart Circ Physiol, May 1, 2004; 286(5): H1767 - H1774. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q.-D. Wang, J. Pernow, P.-O. Sjoquist, and L. Ryden Pharmacological possibilities for protection against myocardial reperfusion injury Cardiovasc Res, July 1, 2002; 55(1): 25 - 37. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P.J. Cowburn and J.G.F. Cleland Endothelin antagonists for chronic heart failure: do they have a role? Eur. Heart J., October 1, 2001; 22(19): 1772 - 1784. [PDF]
|
|
|
|
 |
|
 J. Pernow, A.T. Gonon, and A. Gourine The role of the endothelium for reperfusion injury Eur. Heart J. Suppl., June 1, 2001; 3(suppl_C): C22 - C27. [Abstract] [PDF]
|
|
|
|
|
|
A. V. Gourine, A. T. Gonon, and J. Pernow Involvement of nitric oxide in cardioprotective effect of endothelin receptor antagonist during ischemia-reperfusion Am J Physiol Heart Circ Physiol, March 1, 2001; 280(3): H1105 - H1112. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Galiuto, A. N. DeMaria, U. del Balzo, K. May-Newman, S. F. Flaim, P. L. Wolf, M. Kirchengast, and S. Iliceto Ischemia-Reperfusion Injury at the Microvascular Level : Treatment by Endothelin A-Selective Antagonist and Evaluation by Myocardial Contrast Echocardiography Circulation, December 19, 2000; 102(25): 3111 - 3116. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Dhein, S. Hochreuther, C. a. d. Spring, K. Bollig, C. Hufnagel, and M. Raschack Long-Term Effects of the EndothelinA Receptor Antagonist LU 135252 and the Angiotensin-Converting Enzyme Inhibitor Trandolapril on Diabetic Angiopathy and Nephropathy in a Chronic Type I Diabetes Mellitus Rat Model J. Pharmacol. Exp. Ther., May 1, 2000; 293(2): 351 - 359. [Abstract] [Full Text]
|
|
|
|
 |
|
 G. Caligiuri, B. Levy, J. Pernow, P. Thoren, and G. K. Hansson Myocardial infarction mediated by endothelin receptor signaling in hypercholesterolemic mice PNAS, June 8, 1999; 96(12): 6920 - 6924. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Bugajski, R. Kalawski, I. Zurawska, M. Bartkowiak, H. Wysocki, R. Olszewski, and T. Siminiak Endothelin-1 is involved in plasma mediated stimulation of neutrophil adherence during coronary artery bypass grafting Eur. J. Cardiothorac. Surg., April 1, 1999; 15(4): 408 - 412. [Abstract] [Full Text] [PDF]
|
|